Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer - PubMed

Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer

Irshad Ahmad et al. Eur J Med Chem. 2015.

Abstract

Aromatase, a cytochrome P450 enzyme complex present in breast tissues, plays a significant role in the biosynthesis of important endogenous estrogens from androgens. The source of estrogen production in breast cancer tissues is intra-tumoral aromatase, and inhibition of aromatase may inhibit the growth stimulation effect of estrogens in breast cancer tissues. Consequently, aromatase is considered a useful therapeutic target in the treatment and prevention of estrogen-dependent breast cancer. Recently, different natural products and synthetic compounds have been rapidly developed, studied, and evaluated for aromatase inhibitory activity. Aromatase inhibitors are classified into two categories on the basis of their chemical structures, i.e., steroidal and nonsteroidal aromatase inhibitors. This review highlights the synthetic steroidal and nonsteroidal aromatase inhibitors reported in the literature in the last few years and will aid medicinal chemists in the design and synthesis of novel and pharmacologically-potent aromatase inhibitors for the treatment of breast cancer.

Keywords: Aromatase; Breast cancer; Nonsteroidal aromatase inhibitors; Steroidal aromatase inhibitors.

Similar articles

• Aromatase inhibitors in the treatment of breast cancer.

  Brueggemeier RW, Hackett JC, Diaz-Cruz ES. Brueggemeier RW, et al. Endocr Rev. 2005 May;26(3):331-45. doi: 10.1210/er.2004-0015. Epub 2005 Apr 6. Endocr Rev. 2005. PMID: 15814851 Review.

• Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.

  Yadav MR, Barmade MA, Tamboli RS, Murumkar PR. Yadav MR, et al. Eur J Med Chem. 2015 Nov 13;105:1-38. doi: 10.1016/j.ejmech.2015.09.038. Epub 2015 Oct 3. Eur J Med Chem. 2015. PMID: 26469743 Review.

• Aromatase inhibitors: Role in postmenopausal breast cancer.

  Kharb R, Haider K, Neha K, Yar MS. Kharb R, et al. Arch Pharm (Weinheim). 2020 Aug;353(8):e2000081. doi: 10.1002/ardp.202000081. Epub 2020 May 25. Arch Pharm (Weinheim). 2020. PMID: 32449548 Review.

• A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors.

  Rani S, Raheja K, Luxami V, Paul K. Rani S, et al. Bioorg Chem. 2021 Aug;113:105017. doi: 10.1016/j.bioorg.2021.105017. Epub 2021 May 24. Bioorg Chem. 2021. PMID: 34091288 Review.

• Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.

  Lv W, Liu J, Skaar TC, Flockhart DA, Cushman M. Lv W, et al. J Med Chem. 2015 Mar 26;58(6):2623-48. doi: 10.1021/jm501218e. Epub 2015 Mar 9. J Med Chem. 2015. PMID: 25751283 Free PMC article.

Cited by

• Normal breast epithelial MCF-10A cells to evaluate the safety of carbon dots.

  Vale N, Silva S, Duarte D, Crista DMA, Pinto da Silva L, Esteves da Silva JCG. Vale N, et al. RSC Med Chem. 2020 Dec 10;12(2):245-253. doi: 10.1039/d0md00317d. eCollection 2021 Mar 4. RSC Med Chem. 2020. PMID: 34046613 Free PMC article.

• Design, synthesis, in-silico studies and apoptotic activity of novel amide enriched 2-(1H)- quinazolinone derivatives.

  Gariganti N, Bandi A, Gatta KRSN, Pagag J, Guruprasad L, Poola B, Kottalanka RK. Gariganti N, et al. Heliyon. 2024 Apr 26;10(9):e30292. doi: 10.1016/j.heliyon.2024.e30292. eCollection 2024 May 15. Heliyon. 2024. PMID: 38711664 Free PMC article.

• Investigations on the Degradation of the Bile Salt Cholate via the 9,10-Seco-Pathway Reveals the Formation of a Novel Recalcitrant Steroid Compound by a Side Reaction in Sphingobium sp. Strain Chol11.

  Feller FM, Eilebrecht S, Nedielkov R, Yücel O, Alvincz J, Salinas G, Ludwig KC, Möller H, Philipp B. Feller FM, et al. Microorganisms. 2021 Oct 14;9(10):2146. doi: 10.3390/microorganisms9102146. Microorganisms. 2021. PMID: 34683472 Free PMC article.

• Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis.

  Razak NA, Abu N, Ho WY, Zamberi NR, Tan SW, Alitheen NB, Long K, Yeap SK. Razak NA, et al. Sci Rep. 2019 Feb 6;9(1):1514. doi: 10.1038/s41598-018-37796-w. Sci Rep. 2019. PMID: 30728391 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Chemical Information

  • BindingDB

• Medical

  • MedlinePlus Health Information